EYA2 and breast cancer: In agreement with our finding, knockdown of EYA2 antagonized the SIX1-induced TGF-β signaling, and partially restored epithelial properties with a decrease of the mesenchymal marker fibronectin in breast cancer MCF-7 cells (45).